Reporter’s Notebook: Are One-Shot Gene Editors Ready to Tackle Chronic Illness?
An infusion of Lilly's PCSK9 base editor for hypercholesterolemia has shown early clinical success, expanding gene editing beyond rare diseases. The post Report...
An infusion of Lilly's PCSK9 base editor for hypercholesterolemia has shown early clinical success, expanding gene editing beyond rare diseases. The post Reporter’s Notebook: Are One-Shot Gene Editors Ready to Tackle Chronic Illness? appeared first on Inside Precision Medicine .